References
- Durham ML. Partnerships for research among managed care organizations. Health Aff 17, 111–122 (1998).
- Meenan RT, Goodman MJ, Fishman PA et al Issues in pooling administrative data for economic evaluation. Am. J Manag: Care 8, 45–53, (2002).
- Drummond ME. Experimental versus observational data in the economic evaluation of pharmaceuticals. Med. Decis. Making18, S12—S18 (1998).
- Luce BR, Manning WG, Siegel JE eta]. Estimating costs in cost-effectiveness analysis. In: Cost-Effectiveness in I-kalth and Medicine. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds), Oxford University Press, New York, NY, USA, 176–213 (1996).
- Russell LB, Siegel JE, Daniels N eta]. Cost- effectiveness analysis as a guide to resource allocation in health: roles and limitations. In: Cost-Effectiveness in Health and Medicine. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds), Oxford University Press, New York, NY, USA, 3–24 (1996).
- Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry32, 476-481 (1995–1996).
- Meenan RT, Stevens VJ, Hornbrook MC et al Cost-effectiveness of a hospital-based smoking-cessation intervention. Med. Care 36, 670–678 (1998).
- Hall JE, LaChance PA. An automated participant tracking system using generalized system 1032 data structures. Proceedings of 10th Annual System 1032/ 1022 Users Conference. Boston, MA, USA, System 1032/1022 Users Group (1989).
- Schulman IKA, Buxton M, Glick H et al Results of the economic evaluation of the FIRST study: a multinational prospective economic evaluation. Int. J Ti,chnol. Assess. Healthcare 12, 698–713 (1996).
- Oster G, Borok G, Menzin J eta]. A randomized trial to assess effectiveness and cost in general practice: rationale and design of the Cholesterol Reduction Intervention Study (CRIS). Control. Clin. Trials l6, 3–16 (1995). iiDrummond ME, Davies L. Economic analysis alongside clinical trials: revisiting the methodological issues. Int. J. Ti,chnol. Assess. Healthcare 7, 561–573 (1991).
- Friedman GD. Primer of Epidemiology 4th ed. McGraw-Hill, New York, NY, USA, 199–201 (1994).
- Torrance GW, Siegel JE, Luce BR. Framing and designing the cost-effectiveness analysis. In: Cost-Effectiveness in Health and Medicine. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds), Oxford University Press, New York, NY, USA, 54–81 (1996).
- Hornbrook MC, Goodman MJ, Fishman PA et al Health-based payment and computerized patient record systems. Eff Clin. Pratt. 1, 66–72 (1998).
- Mullahy J, Manning W Statistical issues in cost-effectiveness analyses. In: Valuing Healthcare. Sloan FA (Ed.), Cambridge University Press, New York, NY, USA, 149–184 (1996).
- Krall M, Mysinger T, Pearson J eta]. Integrated clinical database in a health maintenance organization. Medinfo 8, 313–316 (1995).
- Hornbrook MC, Goodman MJ, Fishman PA et al. Building health plan databases to risk adjust outcomes and payments. Int. J Qua'. Healthcare 10, 531–538 (1998).
- •Useful discussion of the interface of automated data systems and cost analyses.
- Luce BR, Elixhauser A. Estimating costs in the economic evaluation of medical technologies. Int. j Technol Assess. Healthcare 6, 57–75 (1990).
- Baumgartner JR. Medicare physician- payment reform and the resource-based relative value scale: a re-creation of efficient market prices? Am. Econ. Rev 82, 1027–1030 (1992).
- Iezzoni LI. Assessing quality using administrative data. Ann. Intern. Med. 127, 666–674 (1997).
- •Informative discussion of the issues surrounding the use of administrative data to assess outcomes.
- Braithwaite WR. Data field standards and the Health Insurance Portability and Accountability Act. Statist. Med. 20, 1323–1330 (2001).
- Carey K. A multilevel modelling approach to analysis of patient costs under managed care. Health Econ. 9, 435–446 (2000).
- Willke RJ, Glick HA, Polsky D, Schulman K. Estimating country-specific cost-effectiveness from multinational clinical trials. Health Econ. 7, 481–493 (1998).
- Schulman K, Burke J, Drummond M et al Resource costing for multinational neurologic clinical trials: methods and results. Health Econ. 7, 629–638 (1998).
- Siegel JE, Weinstein MC, Torrance GW. Reporting cost-effectiveness studies and results. In: Cost-Effectiveness in Health and Medicine. Gold MR, Siegel JE, Russell LB, Weinstein MC (Eds), Oxford University Press, New York, NY, USA, 276–303 (1996).
Websites
- Hanneman RL, Briscoe A. Access-to-data are the key to strong science and solid public policy. Center for Regulatory Effectiveness. www.thecre.com/ guestcolumnists/saltinstitute.html. March 28, 2000.
- National Institutes on Health. NIH announces draft statement on sharing research data. NOT-OD-02-035 http:// grants2.nih.gov/grants/guide/notice-files/ NOT-OD-02-035.html. March 1, 2002.